As of 2025-07-20, the Relative Valuation of Aeglea Bio Therapeutics Inc (AGLE) is (1,553.94) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.01 USD, the upside of Aeglea Bio Therapeutics Inc based on Relative Valuation is -13038.7%.
The range of the Relative Valuation is (1,254.78) - (1,741.86) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.7x - 24.0x | 19.8x |
| Forward P/E multiples | 17.3x - 28.5x | 22.9x |
| Fair Price | (1,254.78) - (1,741.86) | (1,553.94) |
| Upside | -10547.8% - -14603.4% | -13038.7% |
| Date | P/E |